NMDA-ANTAGONIST-PRODRUGS

Patent europeic · EP3066091 · En vigur

Inscripziun en il register

Numer da publicaziun: EP3066091
Numer da la dumonda: EP14802476
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 30-10-2014
Publitgà: 14-09-2016
Concedì: 03-04-2019
La protecziun finescha il pli tard: 29-10-2034
Proxima taxa annuala scadenta: 31-10-2026
Classas IPC: C07D 401/14 (2006.01)
C07D 401/12 (2006.01)
C07D 213/40 (2006.01)
A61K 31/4402 (2006.01)
A61K 31/4439 (2006.01)
A61P 25/24 (2006.01)
Prioritad: US 201361899903 P 05.11.2013
Dumonda PCT: PCT/GB2014/053236 30.10.2014
Publicaziun PCT: WO2015/067923 14.05.2015
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

01-11-2025
Midada
Published in Swissreg on 01.11.2025
01-11-2024
Midada
Published in Swissreg on 01.11.2024
26-01-2024
Midada
Published in Swissreg on 26.01.2024
09-01-2023
Adressa midada
Representative
ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich → Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 09.01.2023
01-11-2022
Midada
Published in Swissreg on 01.11.2022
04-06-2020
Adressa midada
Representative
Servopatent GmbH, Resirain 1, 8125 Zollikerberg → ServoPatent GmbH, Wannerstrasse 9/1, 8045 Zürich
Published in Swissreg on 04.06.2020
04-07-2019
Represchentant inscrit
Representative
Servopatent GmbH, Resirain 1, 8125 Zollikerberg
Published in Swissreg on 04.07.2019
03-04-2019
Concedì
Published in Swissreg on 03.04.2019

Astrazeneca AB

151 85 Södertälje, SE

Bühlstrasse 1, 8125 Zollikerberg

BALESTRA, Michael

Waltham Massachusetts 02451, US

QUIRK, Michael

Waltham Massachusetts 02451, US

BERNSTEIN, Peter

Waltham Massachusetts 02451, US

WEIGELT, Dirk